Abstract: The present disclosure describes ultrasound imaging systems and methods for ultrasonically inspecting biological tissue. An ultrasound imaging system according to the present disclosure may be configured to automatically apply tissue-specific imaging parameter settings (312, 314) based upon the automatic identification of the type of tissue being scanned. Tissue type identification (315) may be performed automatically for the images in the live image stream (304) and thus adjustments to the imaging settings may be applied automatically by using a neural network (320) and thus dynamically during the exam obviating the need for the sonographer to manually switch presets or adjust the imaging settings when moving to different portion of the anatomy.

Abstract: A system and method for ultrasound imaging may involve the use of an ultrasound probe and a processor coupled to the probe and to a source of previously-acquired ultrasound image data. The processor may be configured to receive patient identification information (e.g., responsive to user input and/or supplemented by additional information such a photo of the patient), to determine whether the patient identification information identifies a recurring patient, and if so, to retrieve, from the source of previously-acquired ultrasound image data, previous ultrasound images associated with the recurring patient. The processor may be further configured to generate a current ultrasound image based on signals received from the prove and to apply a neural network to the current ultrasound image and the previous ultrasound images to identify a matching pair of images, such that imaging settings from the matched previous image may be applied to the system for subsequent imaging.

Abstract: Described are benzoimidazole indolyl methane compounds, pharmaceutical compositions containing them, and use of the compounds to inhibit PCSK9-mediated ailments.

Abstract: Described are benzoimidazole indolyl methane compounds, pharmaceutical compositions containing them, and use of the compounds to inhibit PCSK9-mediated ailments.

Abstract: The invention provides in part, compounds according to Formula I: and uses thereof.

Abstract: Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.

Abstract: The invention is directed to compounds according to Formula I: wherein R1, R2a, R2b, R2c, R3, and n are defined below, and to pharmaceutically-acceptable salts thereof. They are cathepsin C inhibitors and can be used in the treatment of diseases mediated by the cathepsin C enzyme, such as COPD.

Abstract: Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.

Abstract: Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.

Abstract: Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.

Abstract: The present invention is directed to novel Muscarinic Acetylcholine receptor antagonists of Formula (I), pharmaceutical compositions and methods of using them. Compounds of Formula (I) are, inter alia, wherein: R1 and R2 are, independently, selected from the group consisting of 3-thienyl, pyridyl, benzyl, pyrimidyl, thiazolyl, isothiazolyl and C3-7cycloalkyl.

Abstract: The present invention provides wood derivatives and composite materials prepared by first solvating a lignocellulosic material using an ionic liquid. The solvated lignocellulosic material can be derivatized to incorporate functional groups, particularly groups that facilitate later combination with polymer materials, including non-polymer polymers. The polymeric materials can be combined with the derivatized lignocellulosic material in solution, or the derivatized lignocellulosic material can be isolated and later combined with the polymeric material in a melt. The invention encompasses a variety of wood derivatives, composites, and nanocomposites useful for preparing multiple types of products, including membranes, fibers, and formed parts.

Abstract: Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.